374 related articles for article (PubMed ID: 11454060)
1. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease.
Kataoka Y; Iwasaki T; Kuroiwa T; Seto Y; Iwata N; Hashimoto N; Ogata A; Hamano T; Kakishita E
Immunology; 2001 Jul; 103(3):310-8. PubMed ID: 11454060
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway.
Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Fujimoto J; Kakishita E
Immunology; 2000 Jan; 99(1):94-100. PubMed ID: 10651946
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells.
Rus V; Svetic A; Nguyen P; Gause WC; Via CS
J Immunol; 1995 Sep; 155(5):2396-406. PubMed ID: 7650373
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function.
Baker MB; Riley RL; Podack ER; Levy RB
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1366-71. PubMed ID: 9037059
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
Via CS; Rus V; Nguyen P; Linsley P; Gause WC
J Immunol; 1996 Nov; 157(9):4258-67. PubMed ID: 8892665
[TBL] [Abstract][Full Text] [Related]
8. Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice.
Sakai T; Kimura Y; Inagaki-Ohara K; Kusugami K; Lynch DH; Yoshikai Y
Gastroenterology; 1997 Jul; 113(1):168-74. PubMed ID: 9207275
[TBL] [Abstract][Full Text] [Related]
9. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.
Shustov A; Luzina I; Nguyen P; Papadimitriou JC; Handwerger B; Elkon KB; Via CS
J Clin Invest; 2000 Sep; 106(6):R39-47. PubMed ID: 10995792
[TBL] [Abstract][Full Text] [Related]
10. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
[TBL] [Abstract][Full Text] [Related]
11. Accumulation and activation-induced release of preformed Fas (CD95) ligand during the pathogenesis of experimental graft-versus-host disease.
Wasem C; Frutschi C; Arnold D; Vallan C; Lin T; Green DR; Mueller C; Brunner T
J Immunol; 2001 Sep; 167(5):2936-41. PubMed ID: 11509642
[TBL] [Abstract][Full Text] [Related]
12. The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.
Okamoto I; Iwaki K; Koya-Miyata S; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Clin Immunol; 2002 May; 103(2):132-44. PubMed ID: 12027418
[TBL] [Abstract][Full Text] [Related]
13. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
[TBL] [Abstract][Full Text] [Related]
14. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
Rao AR; Quinones MP; Garavito E; Kalkonde Y; Jimenez F; Gibbons C; Perez J; Melby P; Kuziel W; Reddick RL; Ahuja SK; Ahuja SS
J Immunol; 2003 Nov; 171(9):4875-85. PubMed ID: 14568968
[TBL] [Abstract][Full Text] [Related]
15. Differential cytokine expression in acute and chronic murine graft-versus-host-disease.
Allen RD; Staley TA; Sidman CL
Eur J Immunol; 1993 Feb; 23(2):333-7. PubMed ID: 8436168
[TBL] [Abstract][Full Text] [Related]
16. Involvement of both donor cytotoxic T lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease.
Onoe Y; Harada M; Tamada K; Abe K; Li T; Tada H; Nomoto K
Immunology; 1998 Oct; 95(2):248-56. PubMed ID: 9824483
[TBL] [Abstract][Full Text] [Related]
17. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.
Imado T; Iwasaki T; Kuroiwa T; Sano H; Hara H
Transplantation; 2004 Feb; 77(3):391-8. PubMed ID: 14966413
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
19. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
Pals ST; Radaszkiewicz T; Gleichmann E
J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion.
Dey BR; Yang YG; Szot GL; Pearson DA; Sykes M
Blood; 1998 May; 91(9):3315-22. PubMed ID: 9558388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
